The Institute for Gene Therapies (IGT) has launched, with the aim of maximizing the potential of gene therapies…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
An abundance of events are afoot around the world to mark Rare Disease Day 2020 on Feb. 29. The…
The Howard University College of Medicine has been awarded a $42,000 grant to support its “LIFE (Learning Is Fundamental…
A recent survey found that U.S. residents are largely interested in and support continued research into the role of human…
To help empower individuals living with sickle cell disease (SCD), biopharmaceutical company Emmaus Life Sciences has teamed up…
California’s legislature has committed $15 million toward sweeping enhancement of adult sickle cell disease (SCD) care in a state…
Ghana is working with Novartis to make hydroxyurea treatment available to people with sickle cell disease, and to open…
The Centers for Disease Control and Prevention (CDC) will share an award total of nearly $1.2 million with institutions in…
During National Sickle Cell Awareness Month, the American Red Cross is asking people to consider making a blood donation…
From walks to blood drives, a host of activities and efforts are marking this year’s National Sickle Cell Awareness Month,…